Darmiyan
Latest round
- Seed
Last raised
- Mar 2020
Total raised
- $10M
Investors
- 11
About Darmiyan
Darmiyan, Inc.Founded in 2016 in San Francisco, US, Darmiyan, Inc. specializes in medical imaging technology aimed at evaluating brain health. The company's founder, Thomas Liebmann, and CEO, Padideh Kamali-Zare, have been pivotal in guiding its mission.Darmiyan specializes in advanced medical imaging technology aimed at improving brain health, particularly in the early detection of neurodegenerative diseases. Their flagship product, BrainSee, is an FDA-approved software designed to evaluate the prognosis of patients diagnosed with amnestic mild cognitive impairment (aMCI). By combining brain MRI data with cognitive test scores, BrainSee generates a score that assesses the likelihood of progression to Alzheimer’s dementia. This innovative product serves healthcare providers, including neurologists and geriatricians, by providing critical insights into patient health and aiding in treatment planning.Darmiyan’s revenue model is based on the provision of their proprietary BrainSee software, which is utilized by healthcare professionals to assess cognitive decline in patients. Revenue is generated primarily through direct sales of the software to medical facilities and clinics, as well as potential partnerships with pharmaceutical companies for research and development purposes. The software is typically offered under a subscription model that allows facilities to access ongoing updates and support. This structure ensures that medical practitioners can effectively use BrainSee in conjunction with their existing diagnostic tools.In March 2020, Darmiyan, Inc. The funds are expected to support the design and launch of new products aimed at expanding its medical imaging portfolio, specifically targeting additional neurological assessments. Darmiyan plans to penetrate new markets in Europe and Asia by 2023, enhancing its global footprint.
Who invested in Darmiyan
11 investors across 2 rounds
See all investors in Darmiyan
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Darmiyan
Who invested in Darmiyan?
Darmiyan has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Darmiyan raised?
Darmiyan has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Darmiyan last raise money?
Darmiyan's most recent round on record is a Seed, in Mar 2020.
What does Darmiyan do?
Darmiyan is a biotechnology company.
Where is Darmiyan headquartered?
Darmiyan is headquartered in San Francisco, US.
Which VCs invest in companies like Darmiyan?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Darmiyan's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Darmiyan? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.